Human FXR Reporter Assay System, 960 Assay Bulk Rgt. Pack for 10x 96-well plates Human PPAR Reporter Assay System, 960 Assay Bulk Rft. Pack for 10x 96-well assay plates Human PPAR Reporter Assay System, 960 Assay Bulk RTgt. Pack for 10x 96-well assay plates Company History INDIGO Biosciences, Inc was founded in 2005 in State College, PA. It remains a privately held biosciences company offering products and services focused on nuclear receptors, which comprise a major class of therapeutic drug targets. The Company's two founders, Dr. Jack Vanden Heuvel and Dr. Blake Peterson, leveraged their collective expertise's in nuclear receptor biology, toxicology, medicinal chemistry and molecular biology to establish the core platform technology of The Company. INDIGO Biosciences' original focus was that of a traditional contract research organization, namely, to provide custom services for the screening of small molecule compounds against functional human and non-human nuclear receptors. Over the years, The Company has demonstrated success in providing quality screening services to clients within the pharmaceutical, biotechnology, food, agriculture and nutriceutical industries, government research agencies, as well as to academic researchers.
Partial Data by Infogroup (c) 2024. All rights reserved.
Partial Data by Foursquare.